ID   PPIF_HUMAN              Reviewed;         207 AA.
AC   P30405; Q2YDB7; Q5W131;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   15-MAR-2017, entry version 165.
DE   RecName: Full=Peptidyl-prolyl cis-trans isomerase F, mitochondrial;
DE            Short=PPIase F;
DE            EC=5.2.1.8;
DE   AltName: Full=Cyclophilin D;
DE            Short=CyP-D;
DE            Short=CypD;
DE   AltName: Full=Cyclophilin F;
DE   AltName: Full=Mitochondrial cyclophilin;
DE            Short=CyP-M;
DE   AltName: Full=Rotamase F;
DE   Flags: Precursor;
GN   Name=PPIF; Synonyms=CYP3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1744118;
RA   Bergsma D.J., Eder C., Gross M., Kersten H., Sylvester D.,
RA   Appelbaum E., Cusimano D., Livi G.P., McLauglin M.M., Kasyan K.,
RA   Porter T.G., Silverman C., Dunnington D., Hand A., Prichett W.P.,
RA   Bossard M.J., Brandt M., Levy M.A.;
RT   "The cyclophilin multigene family of peptidyl-prolyl isomerases.
RT   Characterization of three separate human isoforms.";
RL   J. Biol. Chem. 266:23204-23214(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Blood, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10406942; DOI=10.1046/j.1432-1327.1999.00490.x;
RA   Johnson N., Khan A., Virji S., Ward J.M., Crompton M.;
RT   "Import and processing of heart mitochondrial cyclophilin D.";
RL   Eur. J. Biochem. 263:353-359(1999).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH BCL2.
RX   PubMed=19228691; DOI=10.1074/jbc.M808750200;
RA   Eliseev R.A., Malecki J., Lester T., Zhang Y., Humphrey J.,
RA   Gunter T.E.;
RT   "Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic
RT   effect.";
RL   J. Biol. Chem. 284:9692-9699(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   INTERACTION WITH C1QBP.
RX   PubMed=20950273; DOI=10.1042/BJ20101431;
RA   McGee A.M., Baines C.P.;
RT   "Complement 1q-binding protein inhibits the mitochondrial permeability
RT   transition pore and protects against oxidative stress-induced death.";
RL   Biochem. J. 433:119-125(2011).
RN   [10]
RP   MUTAGENESIS OF CYS-203.
RX   PubMed=21930693; DOI=10.1074/jbc.M111.243469;
RA   Nguyen T.T., Stevens M.V., Kohr M., Steenbergen C., Sack M.N.,
RA   Murphy E.;
RT   "Cysteine 203 of cyclophilin D is critical for cyclophilin D
RT   activation of the mitochondrial permeability transition pore.";
RL   J. Biol. Chem. 286:40184-40192(2011).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH TP53.
RX   PubMed=22726440; DOI=10.1016/j.cell.2012.05.014;
RA   Vaseva A.V., Marchenko N.D., Ji K., Tsirka S.E., Holzmann S.,
RA   Moll U.M.;
RT   "p53 opens the mitochondrial permeability transition pore to trigger
RT   necrosis.";
RL   Cell 149:1536-1548(2012).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   INTERACTION WITH MCUR1.
RX   PubMed=26976564; DOI=10.1073/pnas.1602264113;
RA   Chaudhuri D., Artiga D.J., Abiria S.A., Clapham D.E.;
RT   "Mitochondrial calcium uniporter regulator 1 (MCUR1) regulates the
RT   calcium threshold for the mitochondrial permeability transition.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:E1872-E1880(2016).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.71 ANGSTROMS) OF 43-207.
RX   PubMed=15858260; DOI=10.1107/S0907444905003070;
RA   Schlatter D., Thoma R., Kung E., Stihle M., Muller F., Borroni E.,
RA   Cesura A., Hennig M.;
RT   "Crystal engineering yields crystals of cyclophilin D diffracting to
RT   1.7 A resolution.";
RL   Acta Crystallogr. D 61:513-519(2005).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (0.96 ANGSTROMS) OF 44-207 IN COMPLEX WITH
RP   CYCLOSPORIN A.
RX   PubMed=18076075; DOI=10.1002/prot.21855;
RA   Kajitani K., Fujihashi M., Kobayashi Y., Shimizu S., Tsujimoto Y.,
RA   Miki K.;
RT   "Crystal structure of human cyclophilin D in complex with its
RT   inhibitor, cyclosporin A at 0.96-A resolution.";
RL   Proteins 70:1635-1639(2008).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.54 ANGSTROMS) OF 44-207.
RX   PubMed=21904027; DOI=10.1107/S0907444911023249;
RA   le Maire A., Gelin M., Pochet S., Hoh F., Pirocchi M., Guichou J.F.,
RA   Ferrer J.L., Labesse G.;
RT   "In-plate protein crystallization, in situ ligand soaking and X-ray
RT   diffraction.";
RL   Acta Crystallogr. D 67:747-755(2011).
CC   -!- FUNCTION: PPIases accelerate the folding of proteins. It catalyzes
CC       the cis-trans isomerization of proline imidic peptide bonds in
CC       oligopeptides. Involved in regulation of the mitochondrial
CC       permeability transition pore (mPTP). It is proposed that its
CC       association with the mPTP is masking a binding site for inhibiting
CC       inorganic phosphate (Pi) and promotes the open probability of the
CC       mPTP leading to apoptosis or necrosis; the requirement of the
CC       PPIase activity for this function is debated. In cooperation with
CC       mitochondrial TP53 is involved in activating oxidative stress-
CC       induced necrosis. Involved in modulation of mitochondrial membrane
CC       F(1)F(0) ATP synthase activity and regulation of mitochondrial
CC       matrix adenine nucleotide levels. Has anti-apoptotic activity
CC       independently of mPTP and in cooperation with BCL2 inhibits
CC       cytochrome c-dependent apoptosis. {ECO:0000269|PubMed:19228691,
CC       ECO:0000269|PubMed:22726440}.
CC   -!- CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline
CC       (omega=0).
CC   -!- ENZYME REGULATION: Binds cyclosporin A (CsA). Is displaced by CsA
CC       from the mPTP leading to a lower open probability of the mPTP.
CC   -!- SUBUNIT: Believed to associate with the mitochondrial permeability
CC       transition pore complex (PTPC). Associates with the mitochondrial
CC       membrane ATP synthase F(1)F(0) ATP synthase; the association is
CC       increased by inorganic phosphate (Pi) and decreased by cyclosporin
CC       A (CsA). Interacts with ATP5B; ATP5H and ATP5O. Interacts with
CC       SLC25A3; the interaction is impaired by CsA. Interacts with BCL2;
CC       the interaction is impaired by CsA. Interacts with TP53; the
CC       association implicates preferentially tetrameric TP53, is induced
CC       by oxidative stress and is impaired by CsA. Interacts with C1QBP.
CC       Interacts with MCUR1 (PubMed:26976564).
CC       {ECO:0000269|PubMed:18076075, ECO:0000269|PubMed:19228691,
CC       ECO:0000269|PubMed:20950273, ECO:0000269|PubMed:22726440,
CC       ECO:0000269|PubMed:26976564}.
CC   -!- INTERACTION:
CC       Q9NYB9:ABI2; NbExp=3; IntAct=EBI-5544229, EBI-743598;
CC       Q8N9N5:BANP; NbExp=3; IntAct=EBI-5544229, EBI-744695;
CC       Q96DZ9:CMTM5; NbExp=3; IntAct=EBI-5544229, EBI-2548702;
CC       P04637:TP53; NbExp=4; IntAct=EBI-5544229, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000269|PubMed:10406942}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P30405-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P30405-2; Sequence=VSP_056286;
CC   -!- PTM: Deacteylated at Lys-167 by SIRT3. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the cyclophilin-type PPIase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M80254; AAA58434.1; -; mRNA.
DR   EMBL; AK296669; BAG59266.1; -; mRNA.
DR   EMBL; AL133481; CAH72725.1; -; Genomic_DNA.
DR   EMBL; AL391665; CAH72725.1; JOINED; Genomic_DNA.
DR   EMBL; AL391665; CAI40994.1; -; Genomic_DNA.
DR   EMBL; AL133481; CAI40994.1; JOINED; Genomic_DNA.
DR   EMBL; CH471083; EAW54645.1; -; Genomic_DNA.
DR   EMBL; BC005020; AAH05020.1; -; mRNA.
DR   EMBL; BC110299; AAI10300.1; -; mRNA.
DR   CCDS; CCDS7358.1; -. [P30405-1]
DR   PIR; A41581; A41581.
DR   RefSeq; NP_005720.1; NM_005729.3. [P30405-1]
DR   UniGene; Hs.381072; -.
DR   PDB; 2BIT; X-ray; 1.71 A; X=43-207.
DR   PDB; 2BIU; X-ray; 1.71 A; X=43-207.
DR   PDB; 2Z6W; X-ray; 0.96 A; A/B=44-207.
DR   PDB; 3QYU; X-ray; 1.54 A; A=44-207.
DR   PDB; 3R49; X-ray; 1.77 A; A=43-207.
DR   PDB; 3R4G; X-ray; 1.05 A; A=43-207.
DR   PDB; 3R54; X-ray; 1.35 A; A=43-207.
DR   PDB; 3R56; X-ray; 1.40 A; A=43-207.
DR   PDB; 3R57; X-ray; 1.71 A; A=43-207.
DR   PDB; 3R59; X-ray; 1.10 A; A=43-207.
DR   PDB; 3RCF; X-ray; 1.15 A; A=43-207.
DR   PDB; 3RCG; X-ray; 0.97 A; A=43-207.
DR   PDB; 3RCI; X-ray; 1.44 A; X=43-207.
DR   PDB; 3RCK; X-ray; 1.26 A; X=43-207.
DR   PDB; 3RCL; X-ray; 1.70 A; A=43-207.
DR   PDB; 3RD9; X-ray; 1.40 A; X=43-207.
DR   PDB; 3RDA; X-ray; 1.07 A; X=43-207.
DR   PDB; 3RDB; X-ray; 1.55 A; A=43-207.
DR   PDB; 3RDC; X-ray; 1.94 A; A=43-207.
DR   PDB; 4J58; X-ray; 1.28 A; A=44-207.
DR   PDB; 4J59; X-ray; 1.92 A; A=44-207.
DR   PDB; 4J5A; X-ray; 1.58 A; X=44-207.
DR   PDB; 4J5B; X-ray; 2.01 A; A=44-207.
DR   PDB; 4J5C; X-ray; 1.03 A; X=44-207.
DR   PDB; 4J5D; X-ray; 1.32 A; X=44-207.
DR   PDB; 4J5E; X-ray; 0.99 A; X=44-207.
DR   PDB; 4O8H; X-ray; 0.85 A; A=43-207.
DR   PDB; 4O8I; X-ray; 1.45 A; A=43-207.
DR   PDB; 4XNC; X-ray; 2.23 A; A=44-207.
DR   PDB; 4ZSC; X-ray; 1.50 A; A=44-207.
DR   PDB; 4ZSD; X-ray; 1.45 A; A=44-207.
DR   PDB; 5A0E; X-ray; 1.25 A; A/B=43-207.
DR   PDB; 5CBT; X-ray; 1.45 A; A=44-207.
DR   PDB; 5CBU; X-ray; 1.40 A; A=44-207.
DR   PDB; 5CBV; X-ray; 1.80 A; A=44-207.
DR   PDB; 5CBW; X-ray; 1.80 A; A=44-207.
DR   PDB; 5CCN; X-ray; 1.80 A; A=44-207.
DR   PDB; 5CCQ; X-ray; 1.80 A; A=44-207.
DR   PDB; 5CCR; X-ray; 1.90 A; A=44-207.
DR   PDB; 5CCS; X-ray; 2.10 A; X=44-207.
DR   PDBsum; 2BIT; -.
DR   PDBsum; 2BIU; -.
DR   PDBsum; 2Z6W; -.
DR   PDBsum; 3QYU; -.
DR   PDBsum; 3R49; -.
DR   PDBsum; 3R4G; -.
DR   PDBsum; 3R54; -.
DR   PDBsum; 3R56; -.
DR   PDBsum; 3R57; -.
DR   PDBsum; 3R59; -.
DR   PDBsum; 3RCF; -.
DR   PDBsum; 3RCG; -.
DR   PDBsum; 3RCI; -.
DR   PDBsum; 3RCK; -.
DR   PDBsum; 3RCL; -.
DR   PDBsum; 3RD9; -.
DR   PDBsum; 3RDA; -.
DR   PDBsum; 3RDB; -.
DR   PDBsum; 3RDC; -.
DR   PDBsum; 4J58; -.
DR   PDBsum; 4J59; -.
DR   PDBsum; 4J5A; -.
DR   PDBsum; 4J5B; -.
DR   PDBsum; 4J5C; -.
DR   PDBsum; 4J5D; -.
DR   PDBsum; 4J5E; -.
DR   PDBsum; 4O8H; -.
DR   PDBsum; 4O8I; -.
DR   PDBsum; 4XNC; -.
DR   PDBsum; 4ZSC; -.
DR   PDBsum; 4ZSD; -.
DR   PDBsum; 5A0E; -.
DR   PDBsum; 5CBT; -.
DR   PDBsum; 5CBU; -.
DR   PDBsum; 5CBV; -.
DR   PDBsum; 5CBW; -.
DR   PDBsum; 5CCN; -.
DR   PDBsum; 5CCQ; -.
DR   PDBsum; 5CCR; -.
DR   PDBsum; 5CCS; -.
DR   ProteinModelPortal; P30405; -.
DR   SMR; P30405; -.
DR   BioGrid; 115411; 35.
DR   IntAct; P30405; 14.
DR   MINT; MINT-3011711; -.
DR   STRING; 9606.ENSP00000225174; -.
DR   BindingDB; P30405; -.
DR   ChEMBL; CHEMBL3325306; -.
DR   DrugBank; DB02078; 1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane.
DR   DrugBank; DB08168; 7-AMINO-4-METHYL-CHROMEN-2-ONE.
DR   DrugBank; DB00091; Cyclosporine.
DR   DrugBank; DB00172; L-Proline.
DR   iPTMnet; P30405; -.
DR   PhosphoSitePlus; P30405; -.
DR   SwissPalm; P30405; -.
DR   BioMuta; PPIF; -.
DR   DMDM; 231968; -.
DR   OGP; P30405; -.
DR   UCD-2DPAGE; P30405; -.
DR   EPD; P30405; -.
DR   MaxQB; P30405; -.
DR   PaxDb; P30405; -.
DR   PeptideAtlas; P30405; -.
DR   PRIDE; P30405; -.
DR   TopDownProteomics; P30405-1; -. [P30405-1]
DR   DNASU; 10105; -.
DR   Ensembl; ENST00000225174; ENSP00000225174; ENSG00000108179. [P30405-1]
DR   GeneID; 10105; -.
DR   KEGG; hsa:10105; -.
DR   UCSC; uc001kai.4; human. [P30405-1]
DR   CTD; 10105; -.
DR   DisGeNET; 10105; -.
DR   GeneCards; PPIF; -.
DR   HGNC; HGNC:9259; PPIF.
DR   HPA; HPA077416; -.
DR   MIM; 604486; gene.
DR   neXtProt; NX_P30405; -.
DR   OpenTargets; ENSG00000108179; -.
DR   PharmGKB; PA33584; -.
DR   eggNOG; KOG0865; Eukaryota.
DR   eggNOG; COG0652; LUCA.
DR   GeneTree; ENSGT00760000119119; -.
DR   HOGENOM; HOG000065981; -.
DR   HOVERGEN; HBG001065; -.
DR   InParanoid; P30405; -.
DR   KO; K09565; -.
DR   OMA; VIPAFMC; -.
DR   OrthoDB; EOG091G0BGL; -.
DR   PhylomeDB; P30405; -.
DR   TreeFam; TF312801; -.
DR   BRENDA; 5.2.1.8; 2681.
DR   ChiTaRS; PPIF; human.
DR   EvolutionaryTrace; P30405; -.
DR   GeneWiki; PPIF; -.
DR   GenomeRNAi; 10105; -.
DR   PRO; PR:P30405; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000108179; -.
DR   CleanEx; HS_PPIF; -.
DR   ExpressionAtlas; P30405; baseline and differential.
DR   Genevisible; P30405; HS.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:Ensembl.
DR   GO; GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0016018; F:cyclosporin A binding; IEA:Ensembl.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008637; P:apoptotic mitochondrial changes; IEA:Ensembl.
DR   GO; GO:0071243; P:cellular response to arsenic-containing substance; ISS:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IMP:UniProtKB.
DR   GO; GO:0070266; P:necroptotic process; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0032780; P:negative regulation of ATPase activity; ISS:UniProtKB.
DR   GO; GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB.
DR   GO; GO:0090324; P:negative regulation of oxidative phosphorylation; ISS:UniProtKB.
DR   GO; GO:2000276; P:negative regulation of oxidative phosphorylation uncoupler activity; ISS:UniProtKB.
DR   GO; GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IDA:UniProtKB.
DR   GO; GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; ISS:UniProtKB.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0046902; P:regulation of mitochondrial membrane permeability; ISS:UniProtKB.
DR   GO; GO:1902445; P:regulation of mitochondrial membrane permeability involved in programmed necrotic cell death; IMP:UniProtKB.
DR   GO; GO:0010939; P:regulation of necrotic cell death; IEA:Ensembl.
DR   GO; GO:0010849; P:regulation of proton-transporting ATPase activity, rotational mechanism; ISS:UniProtKB.
DR   GO; GO:0002931; P:response to ischemia; ISS:UniProtKB.
DR   Gene3D; 2.40.100.10; -; 1.
DR   InterPro; IPR029000; Cyclophilin-like_dom.
DR   InterPro; IPR024936; Cyclophilin-type_PPIase.
DR   InterPro; IPR020892; Cyclophilin-type_PPIase_CS.
DR   InterPro; IPR002130; Cyclophilin-type_PPIase_dom.
DR   PANTHER; PTHR11071; PTHR11071; 1.
DR   Pfam; PF00160; Pro_isomerase; 1.
DR   PRINTS; PR00153; CSAPPISMRASE.
DR   SUPFAM; SSF50891; SSF50891; 1.
DR   PROSITE; PS00170; CSA_PPIASE_1; 1.
DR   PROSITE; PS50072; CSA_PPIASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis;
KW   Complete proteome; Isomerase; Mitochondrion; Necrosis;
KW   Reference proteome; Rotamase; S-nitrosylation; Transit peptide.
FT   TRANSIT       1     29       Mitochondrion. {ECO:0000255}.
FT   CHAIN        30    207       Peptidyl-prolyl cis-trans isomerase F,
FT                                mitochondrial.
FT                                /FTId=PRO_0000025489.
FT   DOMAIN       49    205       PPIase cyclophilin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00156}.
FT   MOD_RES      67     67       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99KR7}.
FT   MOD_RES      67     67       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99KR7}.
FT   MOD_RES      86     86       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KR7}.
FT   MOD_RES     167    167       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KR7}.
FT   MOD_RES     175    175       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KR7}.
FT   MOD_RES     190    190       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KR7}.
FT   MOD_RES     203    203       S-nitrosocysteine.
FT                                {ECO:0000250|UniProtKB:Q99KR7}.
FT   VAR_SEQ     139    207       VLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVKEGMD
FT                                VVKKIESFGSKSGRTSKKIVITDCGQLS -> WMASMLCSV
FT                                TSKRAWTS (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056286.
FT   MUTAGEN     203    203       C->S: Blocks Ca(2+)-induced mPTP opening
FT                                and reduces hydrogen peroxide-induced
FT                                cell death.
FT                                {ECO:0000269|PubMed:21930693}.
FT   STRAND       47     54       {ECO:0000244|PDB:4O8H}.
FT   STRAND       57     66       {ECO:0000244|PDB:4O8H}.
FT   TURN         68     70       {ECO:0000244|PDB:4O8H}.
FT   HELIX        72     83       {ECO:0000244|PDB:4O8H}.
FT   TURN         84     86       {ECO:0000244|PDB:4O8H}.
FT   STRAND       94     99       {ECO:0000244|PDB:4O8H}.
FT   TURN        100    102       {ECO:0000244|PDB:4O8H}.
FT   STRAND      103    106       {ECO:0000244|PDB:4O8H}.
FT   TURN        109    111       {ECO:0000244|PDB:4O8H}.
FT   STRAND      112    115       {ECO:0000244|PDB:4O8H}.
FT   STRAND      120    123       {ECO:0000244|PDB:4J5E}.
FT   STRAND      139    142       {ECO:0000244|PDB:4O8H}.
FT   STRAND      144    146       {ECO:0000244|PDB:2Z6W}.
FT   STRAND      150    152       {ECO:0000244|PDB:4O8H}.
FT   STRAND      154    159       {ECO:0000244|PDB:4O8H}.
FT   HELIX       162    164       {ECO:0000244|PDB:4O8H}.
FT   TURN        165    167       {ECO:0000244|PDB:4O8H}.
FT   STRAND      170    176       {ECO:0000244|PDB:4O8H}.
FT   HELIX       178    186       {ECO:0000244|PDB:4O8H}.
FT   STRAND      198    205       {ECO:0000244|PDB:4O8H}.
SQ   SEQUENCE   207 AA;  22040 MW;  D7C76F1D4049F16A CRC64;
     MLALRCGSRW LGLLSVPRSV PLRLPAARAC SKGSGDPSSS SSSGNPLVYL DVDANGKPLG
     RVVLELKADV VPKTAENFRA LCTGEKGFGY KGSTFHRVIP SFMCQAGDFT NHNGTGGKSI
     YGSRFPDENF TLKHVGPGVL SMANAGPNTN GSQFFICTIK TDWLDGKHVV FGHVKEGMDV
     VKKIESFGSK SGRTSKKIVI TDCGQLS
//
